6-K//Foreign company update
NLS Pharmaceutics Ltd. 6-K
Accession 0001213900-25-104162
$NCELCIK 0001783036other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:17 PM ET
Size
53.9 KB
Accession
0001213900-25-104162
Issuer
NewcelX Ltd.
CIK 0001783036
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0001783036
Filing Metadata
- Form type
- 6-K
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:17 PM ET
- Size
- 53.9 KB